Inherited complement regulatory protein deficiency predisposes to human disease in acute injury and chronic inflammatory statesthe examples of vascular damage in atypical hemolytic uremic syndrome and debris accumulation in age-related macular degen
about
Brief report: induction of sustained remission in recurrent catastrophic antiphospholipid syndrome via inhibition of terminal complement with eculizumabProduction of biologically active complement factor H in therapeutically useful quantitiesInhibiting complement activation on cells at the step of C3 cleavage.Genetics and complement in atypical HUS.Autoimmunity: homeostasis of innate immunity gone awry.Complement therapy in atypical haemolytic uraemic syndrome (aHUS).Complement regulators in human disease: lessons from modern genetics.Apolipoprotein B-containing lipoproteins in retinal aging and age-related macular degeneration.Why AMD is a disease of ageing and not of development: mechanisms and insights.Dysregulated complement activation as a common pathway of injury in preeclampsia and other pregnancy complications.Memory-like responses of natural killer cells.Defective complement inhibitory function predisposes to renal disease.The complex nature of serum C3 and C4 as biomarkers of lupus renal flare.Complement system dysregulation and inflammation in the retinal pigment epithelium of a mouse model for Stargardt macular degeneration.Aging, age-related macular degeneration, and the response-to-retention of apolipoprotein B-containing lipoproteins.Anti-mouse properdin TSR 5/6 monoclonal antibodies block complement alternative pathway-dependent pathogenesis.Access to the complement factor B scissile bond is facilitated by association of factor B with C3b protein.Anti-complement activity of the Ixodes scapularis salivary protein Salp20.The role of the immune response in age-related macular degenerationThe alternative complement pathway revisited.Update on hemolytic uremic syndrome: Diagnostic and therapeutic recommendations.Immunology of age-related macular degenerationThe role of cytokines in skin aging.Mechanism of inflammation in age-related macular degeneration: an up-to-date on genetic landmarks.Hepatitis C virus infection upregulates CD55 expression on the hepatocyte surface and promotes association with virus particles.C5a, but not C3a, increases VEGF secretion in ARPE-19 human retinal pigment epithelial cells.Disease-linked mutations in factor H reveal pivotal role of cofactor activity in self-surface-selective regulation of complement activation.Decreased TNF-alpha synthesis by macrophages restricts cutaneous immunosurveillance by memory CD4+ T cells during aging.Recent advances in primary immunodeficiencies: identification of novel genetic defects and unanticipated phenotypes.Diseases of complement dysregulation-an overview.The role of the immune system in kidney disease.From clinical observations and molecular dissection to novel therapeutic strategies for primary immunodeficiency disorders.Atypical hemolytic uremic syndrome
P2860
Q28260452-6C39C149-F62A-4336-A6F5-ADFFE12665DBQ28300280-B336B75B-33EF-4595-ADA2-27C42725B577Q33384196-788EFB00-8D91-47CF-A8C8-0C4BED0E6F1BQ33389945-FD279247-CDE1-433F-BEE0-EA3307B5C5E7Q33403747-AB61BDDA-FBD4-446A-9B07-51CB7014A53BQ33408733-B7D0CA3E-37BD-4010-BB5C-287E604E6149Q33419261-5659E21A-A03B-4829-8EE0-9E85E19991C2Q33634096-A2202E4B-E570-4342-96F5-BA40B53CDE9AQ33879659-ABA9665F-20C9-44D6-BC29-8FA1A8979803Q33976312-CECC5649-11CA-4CE8-A4D3-03240A86E5ADQ34007381-1D2C6842-E662-4113-9E15-7C0C779561F1Q34465747-7A0C1BAE-3DB0-4DE1-843C-3DBD7AC19578Q34905729-D2D34EB0-B7FD-4C30-A62E-11660CD955BFQ34998079-DA4B7D4F-FA1A-44CD-88D9-670201E5F14CQ35056603-749F2458-0216-49FF-9B3B-4EDBEDC2BEE6Q35149952-A6BD36C8-41F2-4496-A42B-E33652534EECQ35372492-DBA53CAE-BADF-40E4-A314-E8B4B894ED18Q36422019-4B551A8B-0173-43A4-9EA7-D58914077708Q36914129-4DD06ECB-8E3C-4F66-892D-78C9DD426110Q37141297-5ED4FB8C-E273-4647-869B-74ABFD551B8DQ37322141-D774D49C-EA91-4A78-9C75-32DB75577B0EQ37614752-C9FB1733-71CB-4B84-A16C-8D46B22332EAQ38105358-C4D55E74-4DE5-4F32-A8E2-D222EC86CDE9Q38173896-453654CC-13FE-4802-B625-72ADB21EFA01Q38315657-506DD395-3B7E-4C70-B338-EA5BE0A8DEC1Q39890415-8D840989-3294-4331-81F1-3C8BEC9856CEQ41377869-837480A8-5FF9-4389-A4EF-0ED5FAF6DB73Q42544608-A4DB5ACC-00A3-44E0-B825-BB4DCF3F486AQ43894530-29133EAC-9877-43A7-A019-7F7C129DBA33Q48256943-C4DC9578-37A8-4D82-8B98-25B1CB11D3B3Q49906802-6022DC7A-B369-4E37-9904-9BDF30EFD64EQ53061634-92B2AE93-BD93-458A-A48B-1557D12E25AFQ56591965-B45CED21-BB1F-4032-89B8-9D120ED291C1
P2860
Inherited complement regulatory protein deficiency predisposes to human disease in acute injury and chronic inflammatory statesthe examples of vascular damage in atypical hemolytic uremic syndrome and debris accumulation in age-related macular degen
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Inherited complement regulator ...... n in age-related macular degen
@ast
Inherited complement regulator ...... n in age-related macular degen
@en
type
label
Inherited complement regulator ...... n in age-related macular degen
@ast
Inherited complement regulator ...... n in age-related macular degen
@en
prefLabel
Inherited complement regulator ...... n in age-related macular degen
@ast
Inherited complement regulator ...... n in age-related macular degen
@en
P1476
Inherited complement regulator ...... n in age-related macular degen
@en
P2093
Anna Richards
John P Atkinson
P304
P356
10.1016/S0065-2776(07)96004-6
P577
2007-01-01T00:00:00Z